Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBSXBoston Scientific
FinDog View：Neutral
| Metric | ABBV | BSX |
|---|
| Close | 294.89 | 41.98 |
| Market Cap | $522B | $61.1B |
| 1M | +12.73% | −3.83% |
| P/E (TTM) | 81.4 | 16.8 |
| Forward P/E | 16.9 | 13.2 |
| P/E 5-Yr Percentile | 62 | 0 |
| P/S | 8.0 | 3.0 |
| P/B | — | 2.5 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $5.4B |
| Revenue YoY | +10.2% | +7.5% |
| Gross Margin | 74.7% | 70.7% |
| Latest Quarter EPS | 2.03 | 0.61 |
| Avg Post-Earnings Move | ±1.7% | ±1.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | — |
| 90-Day Net Insider Buying | −$8.2M | +$9.5M |
ABBV · Revenue, Last 8 Quarters ($B)
BSX · Revenue, Last 8 Quarters ($B)
